PubMed:7815555
Annnotations
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 24-33 | DNA | denotes | CD48 gene |
| T2 | 86-130 | cell_type | denotes | Epstein-Barr virus-immortalized B-cell lines |
| T3 | 157-172 | DNA | denotes | NF-kappa B site |
| T4 | 220-235 | cell_type | denotes | resting B cells |
| T5 | 329-333 | protein | denotes | CD48 |
| T6 | 367-391 | cell_type | denotes | normal activated B cells |
| T7 | 437-453 | DNA | denotes | enhancer element |
| T8 | 461-470 | DNA | denotes | CD48 gene |
| T9 | 538-578 | cell_line | denotes | EBV-positive B-lymphoblastoid cell lines |
| T10 | 639-664 | cell_line | denotes | EBV-negative B-cell lines |
| T11 | 724-748 | cell_type | denotes | lymphoblastoid phenotype |
| T12 | 753-763 | protein | denotes | NF-kappa B |
| T13 | 937-960 | protein | denotes | nuclear protein complex |
| T14 | 1001-1012 | protein | denotes | NF-kappa B1 |
| T15 | 1014-1017 | protein | denotes | p50 |
| T16 | 1050-1087 | protein | denotes | EBV-encoded latent membrane protein 1 |
| T17 | 1131-1135 | protein | denotes | CD48 |
| T18 | 1136-1151 | DNA | denotes | NF-kappa B site |
| T19 | 1164-1178 | DNA | denotes | intact element |
| T20 | 1200-1225 | protein | denotes | latent membrane protein 1 |
| T21 | 1247-1261 | protein | denotes | NF-kappa B/Rel |
| T22 | 1361-1376 | cell_type | denotes | resting B cells |
DisGeNET5_gene_disease
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 7815555-1#155#159#gene962 | 329-333 | gene962 | denotes | CD48 |
| 7815555-1#20#34#diseaseC0149678 | 194-208 | diseaseC0149678 | denotes | EBV) infection |
| 155#159#gene96220#34#diseaseC0149678 | 7815555-1#155#159#gene962 | 7815555-1#20#34#diseaseC0149678 | associated_with | CD48,EBV) infection |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-173 | Sentence | denotes | Characterization of the CD48 gene demonstrates a positive element that is specific to Epstein-Barr virus-immortalized B-cell lines and contains an essential NF-kappa B site. |
| S2 | 174-392 | Sentence | denotes | Epstein-Barr virus (EBV) infection of mature, resting B cells drives them to become lymphoblasts expressing high levels of cell surface molecules, such as CD48, characteristically expressed on normal activated B cells. |
| S3 | 393-579 | Sentence | denotes | Here, we report on the identification of an enhancer element in the CD48 gene which reproducibly confers strong transcriptional activity only in EBV-positive B-lymphoblastoid cell lines. |
| S4 | 580-749 | Sentence | denotes | The element is not activated upon infection of established EBV-negative B-cell lines, indicating that EBV fails to drive these cells to a fully lymphoblastoid phenotype. |
| S5 | 750-908 | Sentence | denotes | An NF-kappa B binding site is an essential component of the element but alone is not sufficient to account for the activity or the specificity of the element. |
| S6 | 909-1045 | Sentence | denotes | We have detected a specific nuclear protein complex that binds to the element and show that NF-kappa B1 (p50) is a part of this complex. |
| S7 | 1046-1397 | Sentence | denotes | The EBV-encoded latent membrane protein 1 is capable of transactivating the isolated CD48 NF-kappa B site but not the intact element, suggesting that the latent membrane protein 1-driven activation of NF-kappa B/Rel must interact with other regulatory pathways to control expression of cellular genes as EBV drives resting B cells into the cell cycle. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 20-33 | NP | denotes | the CD48 gene |
| C2 | 47-65 | NP | denotes | a positive element |
| C3 | 66-70 | NP | denotes | that |
| C4 | 144-172 | NP | denotes | an essential NF-kappa B site |
| C5 | 212-235 | NP | denotes | mature, resting B cells |
| C6 | 243-247 | NP | denotes | them |
| C7 | 329-333 | NP | denotes | CD48 |
| C10 | 457-470 | NP | denotes | the CD48 gene |
| C9 | 434-470 | NP | denotes | an enhancer element in the CD48 gene |
| C11 | 471-476 | NP | denotes | which |
| C8 | 434-578 | NP | denotes | an enhancer element in the CD48 gene which reproducibly confers strong transcriptional activity only in EBV-positive B-lymphoblastoid cell lines |
| C12 | 580-591 | NP | denotes | The element |
| C13 | 627-664 | NP | denotes | established EBV-negative B-cell lines |
| C14 | 682-685 | NP | denotes | EBV |
| C15 | 701-712 | NP | denotes | these cells |
| C16 | 750-776 | NP | denotes | An NF-kappa B binding site |
| C17 | 806-817 | NP | denotes | the element |
| C18 | 896-907 | NP | denotes | the element |
| C19 | 926-960 | NP | denotes | a specific nuclear protein complex |
| C20 | 961-965 | NP | denotes | that |
| C21 | 975-986 | NP | denotes | the element |
| C22 | 1032-1044 | NP | denotes | this complex |
| C23 | 1350-1353 | NP | denotes | EBV |
| C24 | 1361-1376 | NP | denotes | resting B cells |
| R1 | C3 | C2 | coref-relat | that,a positive element |
| R2 | C6 | C5 | coref-pron | them,"mature, resting B cells" |
| R3 | C10 | C7 | coref-ident | the CD48 gene,CD48 |
| R4 | C11 | C9 | coref-relat | which,an enhancer element in the CD48 gene |
| R5 | C12 | C8 | coref-ident | The element,an enhancer element in the CD48 gene which reproducibly confers strong transcriptional activity only in EBV-positive B-lymphoblastoid cell lines |
| R6 | C15 | C13 | coref-ident | these cells,established EBV-negative B-cell lines |
| R7 | C16 | C4 | coref-ident | An NF-kappa B binding site,an essential NF-kappa B site |
| R8 | C17 | C12 | coref-ident | the element,The element |
| R9 | C18 | C17 | coref-ident | the element,the element |
| R10 | C20 | C19 | coref-relat | that,a specific nuclear protein complex |
| R11 | C21 | C18 | coref-ident | the element,the element |
| R12 | C22 | C19 | coref-ident | this complex,a specific nuclear protein complex |
| R13 | C23 | C14 | coref-ident | EBV,EBV |
| R14 | C24 | C5 | coref-ident | resting B cells,"mature, resting B cells" |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 24-33 | DNA_domain_or_region | denotes | CD48 gene |
| T2 | 86-104 | virus | denotes | Epstein-Barr virus |
| T3 | 157-167 | protein_molecule | denotes | NF-kappa B |
| T4 | 174-192 | virus | denotes | Epstein-Barr virus |
| T5 | 194-197 | virus | denotes | EBV |
| T6 | 220-235 | cell_type | denotes | resting B cells |
| T7 | 329-333 | protein_molecule | denotes | CD48 |
| T8 | 367-391 | cell_type | denotes | normal activated B cells |
| T9 | 437-453 | DNA_domain_or_region | denotes | enhancer element |
| T10 | 461-465 | protein_molecule | denotes | CD48 |
| T11 | 505-529 | other_name | denotes | transcriptional activity |
| T12 | 538-541 | virus | denotes | EBV |
| T13 | 639-642 | virus | denotes | EBV |
| T14 | 682-685 | virus | denotes | EBV |
| T15 | 724-748 | cell_type | denotes | lymphoblastoid phenotype |
| T16 | 753-763 | protein_molecule | denotes | NF-kappa B |
| T17 | 937-960 | protein_complex | denotes | nuclear protein complex |
| T18 | 1001-1012 | protein_subunit | denotes | NF-kappa B1 |
| T19 | 1014-1017 | protein_subunit | denotes | p50 |
| T20 | 1050-1053 | virus | denotes | EBV |
| T21 | 1131-1135 | protein_molecule | denotes | CD48 |
| T22 | 1136-1146 | protein_molecule | denotes | NF-kappa B |
| T23 | 1164-1178 | DNA_domain_or_region | denotes | intact element |
| T24 | 1200-1225 | protein_molecule | denotes | latent membrane protein 1 |
| T25 | 1247-1261 | protein_molecule | denotes | NF-kappa B/Rel |
| T26 | 1350-1353 | virus | denotes | EBV |
| T27 | 1361-1376 | cell_type | denotes | resting B cells |
| T28 | 1386-1396 | other_name | denotes | cell cycle |